A series of recalls from India-based company Glenmark Pharmaceuticals has raised concerns about the safety of drugs manufactured overseas and the FDA’s role in ensuring public safety, ProPublica reported Dec. 12.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
